WinstonWınston
RBR Global logo

RBR Global

RBRI
13
Financial - Credit Services · Financial Services
Price
$0.01
-0.01 (-55.00%)
Market Cap
$21.0M
Winston Score
13
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+288.6% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 93.3M (2020) → 362.4M (2024)

RBR Global Inc. is a small financial services company that focuses on credit-related products and services. It operates in the credit services industry, which includes things like lending, credit facilitation, or related financial tools aimed at businesses or consumers. The company has a very limited public profile, making it difficult to identify a single defining product or dominant customer base.

The company generates revenue through financial service fees or credit-related transactions, though its current financials show it is spending far more than it earns, with an operating margin of roughly negative 367%. It appears to be a micro-cap or early-stage firm with minimal scale and no clear geographic footprint on record. The biggest risk facing RBR Global is its ability to survive — the deeply negative margins and near-zero market cap suggest the company is burning cash and has not yet built a sustainable business model, which is a serious concern for its long-term viability.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+90.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (7%)

Research and development spending

Insider Activity

27.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$18,060 cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

RBR Global's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
0.0%
Thin — 0.0% gross margin
Operating Margin
-498216.7%
Losing money on operations — -498216.7%
ROCE
-6.9%
Weak — -6.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-92.6%
Shrinking sales (-92.6% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-635.5%
Burning cash (-635.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial